our Human Resources policy

RESOURCES

Circle Oncodesign Services

The process of discovery and development of a molecule is complex, long and costly. Before making a decision on the offer that best meets your needs, we offer online scientific resources and our latest news to help you get to know us better. Our experts are also at your disposal to help and support you in your research and development program.

Filter by category
  • All
  • Blog
  • Congress
  • Scientific resource
  • Webinar
  • Poster
  • Scientific publication
  • Press release
  • Press coverage
  • News
Filter by category
Circle Oncodesign Services
Congress
24/04/2023

Poster AACR 2023

Discover our Posters presented in AACR Annual Meeting 2023!

Challenges and perspectives in the preclinical development of therapeutic agents against lung fibrosis
Blog
12/04/2023

Challenges and perspectives in the preclinical development of therapeutic agents against lung fibrosis

In this blog, Pauline Bornert examines the current knowledge about pulmonary fibrosis, and preclinical options available to develop new therapeutic solutions.

Scientific paper - Ressources
Poster
03/04/2023

Preclinical evaluation of a chimpanzee adenovirus vector expressing a pre-fusion Spike (BV-AdCoV-1) SARS-CoV-2 intranasal vaccine candidate in golden Syrian hamsters

Download the e-poster and learn more about Chimpanzee Adenovirus vector SARS-CoV-2 intranasal Vaccine Candidate from Oncodesign Services.

Scientific paper - Ressources
Poster
28/03/2023

New target identification and validation platform combining AI in oncology and preclinical pharmacology

The OncoSNIPE® project combines Ai in Oncology and Preclinical Pharmacology to develop a new identification and validation platform. Learn more here

Scientific paper - Ressources
Poster
28/03/2023

DRIVE-Biologics: all the steps from discovery to development of novel biological therapeutics

DRIVE-Biologics aims to optimize your biologics therapeutics and drug discovery through stages of preclinical evaluation to clinical studies. Learn more here

Scientific paper - Ressources
Poster
28/03/2023

OncoTAM, a comprehensive preclinical platform to explore macrophages

OncoTAM targets Tumor Associated Macrophages to develop new Anticancer Therapies in a form of a comprehensive preclinical platform. Learn more here

Scientific paper - Ressources
Poster
28/03/2023

Simultaneous 18F-FDG PET / MR imaging for metastases identification in a disseminated human preclinical melanoma model

Simultaneous 18F-FDG PET / MR imaging for metastases identification in a disseminated human preclinical Melanoma Model. Learn more here

Scientific paper - Ressources
Poster
28/03/2023

Antitumor activity comparison of two somatostatin receptor ligands radiolabeled with Lutetium-177 (SSO110 and DOTA-TATE)

Somatostatin Receptor ligands Antitumor Activity comparison radiolabeled with Lutetium 177 alone or combined with chemotherapy in mice. Learn more here

Congress
14/03/2023

AACR Annual Meeting 2023

The AACR Annual Meeting brings together scientists, clinicians, and other professionals to share the latest advances in cancer science. Learn more here

Scientific publications | Oncodesign Services
Scientific publication
06/03/2023

Comparative Efficacy and Selectivity of Pharmacological Inhibitors of DYRK and CLK Protein Kinases

New study investigates Pharmacological Inhibitors of DYRK and CLK Protein Kinases and their comparative efficacy and selectivity. Learn more here

Scientific publications | Oncodesign Services
Scientific publication
02/03/2023

A Rhenium(I)-Diselenoether Compound Significantly Decreased the Viral Load of SARS-CoV-2 in Infected Pulmonary Cells

Rhenium(I) tricarbonyl complexes inhibited the 3- chymotrypsin-like protease (3CLpro) which is one of the main proteases of the severe acute respiratory syndrome—coronavirus 2 (SARS-CoV-2 virus), but the antiviral effect was not studied.

Scientific resource
21/02/2023

IBD Case study

Discover an example of a screening cascade developed by Oncodesign Services that led to the identification of preclinical candidates.